Ebola studies reveal new findings on survivors, vaccine

As the Ebola outbreak winds down in West Africa, with no cases reported again last week, researchers reported new findings about complications in survivors and about clinical trial findings for one of the candidate vaccines, ChAd3. Meanwhile, the World Health Organization (WHO) said in its weekly update that no new cases have been reported from the outbreak region, keeping Guinea on track for being declared free of the disease on Dec 28 and Liberia on course for its anticipated Ebola-free date of Jan 14. Sierra Leone reached the end of Ebola transmission on Nov 7. In its overview, the WHO said outbreak totals are at 28,601 confirmed, probable, and suspected cases, along with 11,300 deaths. Large survivor study included detailed work-ups In the largest study of survivors so far, a Canadian-led research team reported on 227 individuals who were treated at a specialized clinic in Sierra Leone’s Port Loko district, which was one of...